(Q51842272)

English

Zerumbone abolishes RANKL-induced NF-kappaB activation, inhibits osteoclastogenesis, and suppresses human breast cancer-induced bone loss in athymic nude mice.

scientific article published on 3 February 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/19190327

retracted paper

2 references

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

Zerumbone abolishes RANKL-induced NF-kappaB activation, inhibits osteoclastogenesis, and suppresses human breast cancer-induced bone loss in athymic nude mice. (English)

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/19190327

1 reference

based on heuristic

inferred from title

author name string

Bokyung Sung

1

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/19190327

Akira Murakami

2

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/19190327

Babatunde O Oyajobi

3

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/19190327

Bharat B Aggarwal

4

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/19190327

language of work or name

0 references

publication date

3 February 2009

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/19190327

Cancer Research

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/19190327

69

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/19190327

4

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/19190327

1477-1484

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/19190327

Genetic regulation of osteoclast development and function

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-3249

Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-3249

A study of the biological receptor activator of nuclear factor-kappaB ligand inhibitor, denosumab, in patients with multiple myeloma or bone metastases from breast cancer

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-3249

Nuclear factor-kappaB and STAT3 are constitutively active in CD138+ cells derived from multiple myeloma patients, and suppression of these transcription factors leads to apoptosis

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-3249

Zerumbone abolishes NF-kappaB and IkappaBalpha kinase activation leading to suppression of antiapoptotic and metastatic gene expression, upregulation of apoptosis, and downregulation of invasion

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-3249

Mechanisms of bone metastasis

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-3249

Chemoprevention of azoxymethane-induced rat aberrant crypt foci by dietary zerumbone isolated from Zingiber zerumbet

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-3249

Suppression of dextran sodium sulfate-induced colitis in mice by zerumbone, a subtropical ginger sesquiterpene, and nimesulide: separately and in combination.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-3249

Interactions between cancer and bone marrow cells induce osteoclast differentiation factor expression and osteoclast-like cell formation in vitro

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-3249

Metastatic bone disease: clinical features, pathophysiology and treatment strategies

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-3249

Zerumbone, a sesquiterpene in subtropical ginger, suppresses skin tumor initiation and promotion stages in ICR mice

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-3249

Missing pieces in the NF-kappaB puzzle

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-3249

Osteoclast differentiation and activation

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-3249

Advances in the biology and treatment of myeloma bone disease

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-3249

Biochemical bone markers in breast cancer

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-3249

Identification of zerumbone in Zingiber zerumbet Smith as a potent inhibitor of 12-O-tetradecanoylphorbol-13-acetate-induced Epstein-Barr virus activation

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-3249

Metastasis to bone: causes, consequences and therapeutic opportunities

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-3249

Oral squamous cell carcinoma cells induce osteoclast differentiation by suppression of osteoprotegerin expression in osteoblasts

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-3249

Myeloma cells can directly contribute to the pool of RANKL in bone bypassing the classic stromal and osteoblast pathway of osteoclast stimulation.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-3249

Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-3249

OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-3249

Osteoprotegerin reduces osteoclast numbers and prevents bone erosion in collagen-induced arthritis

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-3249

RANKL and RANK as novel therapeutic targets for arthritis

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-3249

Prostaglandin E2 enhances osteoclastic differentiation of precursor cells through protein kinase A-dependent phosphorylation of TAK1.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-3249

Nuclear factor-kappaB: the enemy within

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-3249

Signalling pathways of the TNF superfamily: a double-edged sword

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-3249

The IkappaB function of NF-kappaB2 p100 controls stimulated osteoclastogenesis

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-3249

Bisphosphonate-induced necrosis of the jaws: a reconstructive nightmare

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-3249

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-3249

Antitumor effects of zerumbone from Zingiber zerumbet in P-388D1 cells in vitro and in vivo

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-3249

Receptor activator of nuclear factor-kappa b ligand activates nuclear factor-kappa b in osteoclast precursors

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-3249

Mechanisms of TNF-alpha- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-3249

Requirement for NF-kappaB in osteoclast and B-cell development

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-3249

TAT fusion proteins containing tyrosine 42-deleted IkappaBalpha arrest osteoclastogenesis

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-3249

Direct inhibition of NF-kappa B blocks bone erosion associated with inflammatory arthritis

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-3249

NF-kappa B activation in human breast cancer specimens and its role in cell proliferation and apoptosis

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-3249

RANKL stimulates inducible nitric-oxide synthase expression and nitric oxide production in developing osteoclasts. An autocrine negative feedback mechanism triggered by RANKL-induced interferon-beta via NF-kappaB that restrains osteoclastogenesis an

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-3249

NF-kappaB in breast cancer cells promotes osteolytic bone metastasis by inducing osteoclastogenesis via GM-CSF.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-3249

Zerumbone exerts a beneficial effect on inflammatory parameters of cholecystokinin octapeptide-induced experimental pancreatitis but fails to improve histology.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-3249

Cellular mechanisms of bone resorption in breast carcinoma

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-3249

The natural history, skeletal complications, and management of bone metastases in patients with prostate carcinoma

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-3249

Fisetin, an inhibitor of cyclin-dependent kinase 6, down-regulates nuclear factor-kappaB-regulated cell proliferation, antiapoptotic and metastatic gene products through the suppression of TAK-1 and receptor-interacting protein-regulated IkappaBalph

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-3249

The IkappaB kinase (IKK) inhibitor, NEMO-binding domain peptide, blocks osteoclastogenesis and bone erosion in inflammatory arthritis

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-3249

Bisphosphonate use and the risk of adverse jaw outcomes: a medical claims study of 714,217 people

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-3249

NF-kappaB-inducing kinase and IkappaB kinase participate in human T-cell leukemia virus I Tax-mediated NF-kappaB activation

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-08-3249

Identifiers

10.1158/0008-5472.CAN-08-3249

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/19190327

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/19190327

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51842272&oldid=2073829503"